Hospitals are becoming dangerous places to spend time. Even if your treatment goes smoothly, a superbug could get you, with very serious, life-altering consequences — including possibly death. Here are eight superbugs that are…
Thirty out of 49 major developed countries could see their credit ratings plummet to junk status if they don’t make changes soon, says a Standard & Poor’s study. The biggest problem is health care spending on the elderly, parti…
French pharmaceutical giant Sanofi-Aventis says its multiple sclerosis drug teriflunomide significantly cut relapses in patients who took the once-daily oral treatment.
Continue reading Sanofi Says MS Drug Redu…
CVS Caremark has agreed to pay $77.6 million in fines for illegally selling a chemical, common in some cold and cough medicines, that ended up being used to make methamphetamine.
Continue reading CVS to Pay $77…
With King in its fold, Pfizer — which makes Lyrica and Celebrex — believes it can build an industry-leading portfolio of pain relievers. Among King’s most appealing entrants in that market is the new Embeda, designed to preve…